Document is current
Any future updates will be listed below
-
Authors
Weizman, Adam V.
Sharma, Robyn
Afzal, N. M.
Xu, Wei
Walsh, Scott
Stempak, Joanne M.
Nguyen, Geoffrey C.
Croitoru, Ken
Steinhart, A. Hillary
Silverberg, Mark S.
-
Funding
Funding for this research was provided by:
the Mount Sinai Hospital Department of Medicine Pilot Study Research Award
- License Information
-
More Information
Article History
Received: 19 July 2017
Accepted: 24 April 2018
First Online: 8 May 2018
Compliance with ethical standards
:
: AVW has served as a speaker and on advisory boards for Janssen, Takeda, and Abbvie and on an advisory board for Ferring. AHS has received research support from Abbvie, Janssen, Takeda, Pfizer, Millenium, Hoffman Laroche, Genentech, Celgene, Reh Hill Biopharma, Amgen and Arena, has been a consultant for Hospira, Merck, Pharmascience, and Hoffman Laroche, served on advisory boards for Abbvie, Jannsen, Takeda, Ferring, Hospira, Merck, Pharmasience, and Shire and as a speaker for Abbvie, Janssen, Takeda, Ferring, Pfizer, and Hospira. KC has received research support from Abbvie and Janssen, educational grant funding from Abbvie, Takeda, and Janssen, and served on an advisory board for Takeda. MSS has received research support and consulting feeds from Janssen, Abbvie, Takeda, and Prometheus. SW has been on advisory boards for Abbvie, Novartis, and Amgen. The remaining authors disclose no conflicts of interest.
